Início Mini-currículo Equipe médica Publicações Atendimento Contato
Agendar consulta
Produção científica

Publicações

Publicações científicas

Artigos em periódicos e resumos

Seleção de trabalhos científicos com participação do Dr. Lucas V. dos Santos, dispostos por relevância. Cada item traz o link para o artigo ou para seu registro oficial.

1
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Fuchs CS, Tomasek J, … dos Santos LV, et al.
Lancet 2014, 383:31
Ver artigo ↗
2
Independent radiologic review in metastatic colorectal cancer: systematic review and meta-analysis
Lima JPSN, de Souza FH, de Andrade DAP, Carvalheira JBC, dos Santos LV
Radiology 2012, 263:86
Ver artigo ↗
3
Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review
dos Santos LV, Souza FH, Brunetto AT, Sasse AD, Lima JPSN
J Natl Cancer Inst 2012, 104:1280
Ver artigo ↗
4
Timing of adjuvant chemotherapy in colorectal cancer
dos Santos LV, Veiga Faria TM, Lima ABC, et al.
Colorectal Dis 2016, 18:871
Ver artigo ↗
5
Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomised trials
Macedo LT, Lima JPN, dos Santos LV, Sasse AD
Support Care Cancer 2014, 22:1585
Ver artigo ↗
6
Curative-intent surgery for pancreatic tumors: a review of procedures from the Brazilian National Health System
dos Santos LV, Lessa MAO, Lima JPSN, Haaland B, Lopes GL
JCO Glob Oncol 2017, 3:37
Ver artigo ↗
7
Optimal duration of first-line chemotherapy for advanced non-small cell lung cancer: a systematic review with meta-analysis
Lima JPSN, dos Santos LV, Sasse EC, Sasse AD
Eur J Cancer 2009, 45:601
Ver artigo ↗
8
HER2 status in gastric and gastroesophageal junction cancer
Kim WH, Gomez-Izquierdo L, Vilardell F, … dos Santos LV, et al.
Appl Immunohistochem Mol Morphol 2018, 26:239
Ver artigo ↗
9
Metformin plus irinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial
Bragagnoli AC, Araujo RLC, Ferraz MW, dos Santos LV, et al.
Br J Cancer 2021, 124:1072
Ver artigo ↗
10
Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be not better
Sasse AD, Lima JP, Sasse EC, dos Santos LV
J Clin Oncol 2009, 27:e253
Ver artigo ↗
11
Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer
Lima JPSN, dos Santos LV, Sasse EC, Lima CSP, Sasse AD
J Thorac Oncol 2010, 5:1986
Ver artigo ↗
12
Overcoming resistance to immune checkpoint inhibitors in head and neck squamous cell carcinomas
dos Santos LV, Abrahão CM, William WN
Front Oncol 2021, 11:596290
Ver artigo ↗
13
Differentiated thyroid carcinoma: what the nonspecialists need to know
Hoff AO, Chaves ALF, de Oliveira TB, … dos Santos LV, et al.
Arch Endocrinol Metab 2024, 68:e230375
Ver artigo ↗
14
Charge for peer reviewing
dos Santos LV
Einstein (Sao Paulo) 2014, 12:534
Ver artigo ↗
15
Consensus on treatment and follow-up for biochemical recurrence in castration-sensitive prostate cancer: a report from the First Global Prostate Cancer Consensus Conference for Developing Countries
Monteiro FSM, Schutz FA, Morbeck IAP, … dos Santos LV, et al.
JCO Glob Oncol 2021, 7:538
Ver artigo ↗
16
Abstract P1-17-10: Survival outcomes related to health care coverage in breast cancer patients with brain metastases in Brazil: a sub-analysis from the LACOG-0312 study
Albuquerque C, Debiasi M, Werutsky G, … dos Santos LV, et al.
Cancer Res 2018, 78:P1-17-10
Ver artigo ↗
17
Consensus on the treatment and follow-up for metastatic castration-resistant prostate cancer: a report from the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
Maluf FC, Pereira FMT, Silva AG, … dos Santos LV, et al.
JCO Glob Oncol 2021, 7:559
Ver artigo ↗
18
Age does not influence efficacy of ramucirumab in advanced gastric cancer: subgroup analyses of REGARD and RAINBOW
Muro K, Cho JY, Bodoky G, … dos Santos LV, et al.
J Gastroenterol Hepatol 2018, 33:814
Ver artigo ↗
19
Abstract P6-16-04: Real world data and patterns of care of metastatic breast cancer (MBC) in Brazil: first results of LACOG 0312 retrospective study
Barrios CH, Uema D, Cronenberger E, … dos Santos L, et al.
Cancer Res 2017, 77:P6-16-04
Ver artigo ↗
20
VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis
dos Santos LV, Cruz MR, Lima Lopes G, Lima JPSN
Breast Cancer Res Treat 2015, 151:481
Ver artigo ↗
21
Important clinical findings for chemotherapy-induced nausea and vomiting: commentary on Molassiotis et al.
dos Santos LV, Lima JP
J Pain Symptom Manage 2014, 47:827
Ver artigo ↗
22
Nanoknife and hepatic embolization for colorectal cancer liver metastases
Cruz MRS, de Lima Lopes G, dos Santos LV
Curr Colorectal Cancer Rep 2014, 10:76
Ver artigo ↗
23
Imatinib-induced bone edema: case report and review of literature
dos Santos LV, Lima JP, Abdalla K, et al.
J Natl Compr Canc Netw 2013, 11:1187
Ver artigo ↗
24
O-0008 REGARD phase 3, randomized trial of ramucirumab in patients with metastatic gastric or GEJ adenocarcinoma following progression on first-line chemotherapy
Tabernero J, Tomasek J, Filip D, … dos Santos L, et al.
Ann Oncol 2013, 24:iv14
Ver artigo ↗
25
Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-analysis
dos Santos LV, Lima JPSN, Lima CSP, Sasse EC, Sasse AD
BMC Cancer 2012, 12:288
Ver artigo ↗
26
Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma
dos Santos LV, Carvalho AL
Recent Pat Anticancer Drug Discov 2011, 6:45
Ver artigo ↗
27
Bevacizumab in metastatic colorectal cancer and carcino-embryonic antigen kinetics
de Andrade DP, Lima JP, Lima AD, Sasse AD, dos Santos LV
Anticancer Drugs 2011, 22:S15
Ver artigo ↗
28
FOLFIRINOX: a great leap forward, but for whom?
dos Santos LV, de Andrade DP, Lima JP
J Clin Oncol 2012, 30:114
Ver artigo ↗
29
Japanese patients equally likely to benefit from aprepitant for chemotherapy-induced nausea and vomiting prevention
Lima JPSN, Nakamura RA, dos Santos LV
Cancer Sci 2011, 102:1112
Ver artigo ↗
30
Watch and wait policy remains experimental for the management of rectal cancer
dos Santos LV, Jácome AAA, Cárcano FM, Lima JPSN, Serrano SV
Colorectal Dis 2010, 12:833
Ver artigo ↗
← Voltar ao início